Systems approach to characterize the metabolism of liver cancer stem cells expressing CD133

Scientific Reports

Volumn 7, Issue , 2017, Pages

  Hur, Wonhee ^a   Ryu, Jae Yong ^b   Kim, Hyun Uk ^b   Hong, Sung Woo ^a   Lee, Eun Byul ^a   Lee, Sang Yup ^b   Yoon, Seung Kew ^a,c  

^a The Catholic University of Korea   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; PROM1 PROTEIN, MOUSE; TRANSCRIPTOME;

ANIMAL; APOPTOSIS; BAGG ALBINO MOUSE; CANCER STEM CELL; CELL MOTION; CELL PROLIFERATION; DRUG SCREENING; FEMALE; GENETICS; HUMAN; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; METABOLOME; MOUSE; NUDE MOUSE; PATHOLOGY; SIGNAL TRANSDUCTION; SYSTEM ANALYSIS; TUMOR CELL CULTURE;

AC133 ANTIGEN; ANIMALS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; HUMANS; LIVER NEOPLASMS; METABOLOME; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASTIC STEM CELLS; SIGNAL TRANSDUCTION; SYSTEMS ANALYSIS; TRANSCRIPTOME; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 85016976327     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep45557     Document Type: Article

References (53)

1. Crissien, A. M., & Frenette, C. Current management of hepatocellular carcinoma. Gastroenterol Hepatol (N Y) 10, 153-161 (2014
2. Yu, S. J. A concise review of updated guidelines regarding the management of hepatocellular carcinoma around the world: 2010-2016. Clin. Mol. Hepatol. 22, 7-17, doi: 10.3350/cmh.2016.22.1.7 (2016
3. Marquardt, J. U., Galle, P. R., & Teufel, A. Molecular diagnosis and therapy of hepatocellular carcinoma (HCC): an emerging field for advanced technologies. J. Hepatol. 56, 267-275, doi: 10.1016/j.jhep.2011.07.007 (2012
4. Sherman, M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin. Liver Dis. 30, 3-16, doi: 10.1055/s-0030-1247128 (2010
5. El-Serag, H. B., Marrero, J. A., Rudolph, L., & Reddy, K. R. Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology 134, 1752-1763, doi: 10.1053/j.gastro.2008.02.090 (2008
6. Rampone, B., Schiavone, B., & Confuorto, G. Current management of hepatocellular cancer. Curr. Oncol. Rep. 12, 186-192, doi: 10.1007/s11912-010-0094-3 (2010
7. Knizetova, P., Darling, J. L., & Bartek, J. Vascular endothelial growth factor in astroglioma stem cell biology and response to therapy. J. Cell. Mol. Med. 12, 111-125, doi: 10.1111/j.1582-4934.2007.00153.x (2008
8. Iwasaki, H., & Suda, T. Cancer stem cells and their niche. Cancer Sci. 100, 1166-1172, doi: 10.1111/j.1349-7006.2009.01177.x (2009
9. Yamashita, T., & Wang, X. W. Cancer stem cells in the development of liver cancer. J. Clin. Invest. 123, 1911-1918, doi: 10.1172/JCI66024 (2013
10. Wang, B., & Jacob, S. T. Role of cancer stem cells in hepatocarcinogenesis. Genome Med. 3, 11, doi: 10.1186/gm225 (2011
11. Marquardt, J. U., Factor, V. M., & Thorgeirsson, S. S. Epigenetic regulation of cancer stem cells in liver cancer: current concepts and clinical implications. J. Hepatol. 53, 568-577, doi: 10.1016/j.jhep.2010.05.003 (2010
12. Lai, F. B., et al. Lipopolysaccharide supports maintaining the stemness of CD133(+ ) hepatoma cells through activation of the NFkappaB/HIF-1alpha pathway. Cancer Lett. 378, 131-141, doi: 10.1016/j.canlet.2016.05.014 (2016
13. Hong, S. W., et al. Role of ADAM17 in invasion and migration of CD133-expressing liver cancer stem cells after irradiation. Oncotarget 7, 23482-23497, doi: 10.18632/oncotarget.8112 (2016
14. Nomura, A., et al. Microenvironment mediated alterations to metabolic pathways confer increased chemo-resistance in CD133+ tumor initiating cells. Oncotarget, doi: 10.18632/oncotarget.10838 (2016
15. Lee, Y. K., et al. Knockdown of 14-3-3zeta enhances radiosensitivity and radio-induced apoptosis in CD133(+ ) liver cancer stem cells. Exp. Mol. Med. 46, e77, doi: 10.1038/emm.2013.151 (2014
16. Piao, L. S., et al. CD133+ liver cancer stem cells modulate radioresistance in human hepatocellular carcinoma. Cancer Lett. 315, 129-137, doi: 10.1016/j.canlet.2011.10.012 (2012
17. Ryu, J. Y., Kim, H. U., & Lee, S. Y. Reconstruction of genome-scale human metabolic models using omics data. Integr. Biol. 7, 859-868, doi: 10.1039/c5ib00002e (2015
18. Cong, N., Li, Z., Shao, W., Li, J., & Yu, S. Activation of ETA receptor by endothelin-1 induces hepatocellular carcinoma cell migration and invasion via ERK1/2 and AKT signaling pathways. J. Membr. Biol. 249, 119-128, doi: 10.1007/s00232-015-9854-1 (2016
19. Lu, J. W., et al. Overexpression of endothelin 1 triggers hepatocarcinogenesis in zebrafish and promotes cell proliferation and migration through the AKT pathway. PLoS One 9, e85318, doi: 10.1371/journal.pone.0085318 (2014
20. Tang, K. H., et al. CD133(+ ) liver tumor-initiating cells promote tumor angiogenesis, growth, and self-renewal through neurotensin/interleukin-8/CXCL1 signaling. Hepatology 55, 807-820, doi: 10.1002/hep.24739 (2012
21. Hosios, A. M., et al. Amino acids rather than glucose account for the majority of cell mass in proliferating mammalian cells. Dev. Cell 36, 540-549, doi: 10.1016/j.devcel.2016.02.012 (2016
22. Hoshino, J., Kuhne, U., & Kroger, H. Enhancement of DNA synthesis and cell proliferation by 1-methylnicotinamide in rat liver cells in culture: implication for its in vivo role. Biochem. Biophys. Res. Commun. 105, 1446-1452 (1982
23. Kuykendall, J. R., Cox, R., & Kinder, D. 1-Methylnicotinamide stimulates cell growth and inhibits hemoglobin synthesis in differentiating murine erythroleukemia cells. Toxicol. In Vitro 21, 1656-1662 (2007
24. Bull, C., Stoel, M. A., den Brok, M. H., & Adema, G. J. Sialic acids sweeten a tumor?s life. Cancer Res. 74, 3199-3204, doi: 10.1158/0008-5472.CAN-14-0728 (2014
25. Bull, C., et al. Targeting aberrant sialylation in cancer cells using a fluorinated sialic acid analog impairs adhesion, migration, and in vivo tumor growth. Mol. Cancer Ther. 12, 1935-1946, doi: 10.1158/1535-7163.MCT-13-0279 (2013
26. Rillahan, C. D., et al. Global metabolic inhibitors of sialyl- And fucosyltransferases remodel the glycome. Nat. Chem. Biol. 8, 661-668, doi: 10.1038/nchembio.999 (2012
27. Mardinoglu, A., et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-Alcoholic fatty liver disease. Nat. Commun. 5, 3083, doi: 10.1038/ncomms4083 (2014
28. Agren, R., et al. Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol. Syst. Biol. 10, 721 (2014
29. Liu, T., et al. The transcriptional profiling of glycogenes associated with hepatocellular carcinoma metastasis. PLoS One 9, e107941, doi: 10.1371/journal.pone.0107941 (2014
30. Lee, K. H., Park, J. H., Kim, T. Y., Kim, H. U., & Lee, S. Y. Systems metabolic engineering of Escherichia coli for L-Threonine production. Mol. Syst. Biol. 3, 149, doi: 10.1038/msb4100196 (2007
31. Liu, Z. P., Wu, C., Miao, H., & Wu, H. RegNetwork: an integrated database of transcriptional and post-Transcriptional regulatory networks in human and mouse. Database (Oxford), doi: 10.1093/database/bav095 (2015
32. Dang, C. V., Le, A., & Gao, P. MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin. Cancer Res. 15, 6479-6483, doi: 10.1158/1078-0432.CCR-09-0889 (2009
33. Dang, C. V. Rethinking the Warburg effect with Myc micromanaging glutamine metabolism. Cancer Res. 70, 859-862, doi: 10.1158/0008-5472.CAN-09-3556 (2010
34. Gao, P., et al. c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458, 762-765, doi: 10.1038/nature07823 (2009
35. Wise, D. R., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc. Natl. Acad. Sci. USA 105, 18782-18787, doi: 10.1073/pnas.0810199105 (2008
36. Plutzky, J. The PPAR-RXR transcriptional complex in the vasculature: energy in the balance. Circ. Res. 108, 1002-1016, doi: 10.1161/CIRCRESAHA.110.226860 (2011
37. Piqueras, L., et al. Activation of PPARbeta/delta induces endothelial cell proliferation and angiogenesis. Arterioscler. Thromb. Vasc. Biol. 27, 63-69, doi: 10.1161/01.ATV.0000250972.83623.61 (2007
38. Beloribi-Djefaflia, S., Vasseur, S., & Guillaumond, F. Lipid metabolic reprogramming in cancer cells. Oncogenesis 5, e189, doi: 10.1038/oncsis.2015.49 (2016
39. Currie, E., Schulze, A., Zechner, R., Walther, T. C., & Farese, R. V. Jr. Cellular fatty acid metabolism and cancer. Cell Metab. 18, 153-161, doi: 10.1016/j.cmet.2013.05.017 (2013
40. Akie, T. E., Liu, L., Nam, M., Lei, S., & Cooper, M. P. OXPHOS-Mediated Induction of NAD+ Promotes Complete Oxidation of Fatty Acids and Interdicts Non-Alcoholic Fatty Liver Disease. PLoS One 10, e0125617, doi: 10.1371/journal.pone.0125617 (2015
41. Lin, Z., & Fang, D. The roles of SIRT1 in cancer. Genes Cancer 4, 97-104, doi: 10.1177/1947601912475079 (2013
42. Simmons, G. E., Jr., Pruitt, W. M., & Pruitt, K. Diverse roles of SIRT1 in cancer biology and lipid metabolism. Int. J. Mol. Sci. 16, 950-965, doi: 10.3390/ijms16010950 (2015
43. LeBleu, V. S., et al. PGC-1alpha mediates mitochondrial biogenesis and oxidative phosphorylation in cancer cells to promote metastasis. Nat. Cell Biol. 16, 992-1003 1001-1015, doi: 10.1038/ncb3039 (2014
44. Scarpulla, R. C. Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochim. Biophys. Acta 1813, 1269-1278, doi: 10.1016/j.bbamcr.2010.09.019 (2011
45. Schreurs, M., Kuipers, F., & van der Leij, F. R. Regulatory enzymes of mitochondrial beta-oxidation as targets for treatment of the metabolic syndrome. Obes. Rev. 11, 380-388, doi: 10.1111/j.1467-789X.2009.00642.x (2010
46. Jang, K. Y., et al. SIRT1 and c-Myc promote liver tumor cell survival and predict poor survival of human hepatocellular carcinomas. PLoS One 7, e45119, doi: 10.1371/journal.pone.0045119 (2012
47. Ulitsky, I., et al. Expander: from expression microarrays to networks and functions. Nat. Protoc. 5, 303-322, doi: 10.1038/nprot.2009.230 (2010
48. Huang da, W., Sherman, B. T.& Lempicki, R. A.Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4, 44-57, doi: 10.1038/nprot.2008.211 (2009
49. Agren, R., et al. The RAVEN toolbox and its use for generating a genome-scale metabolic model for Penicillium chrysogenum. PLoS Comput. Biol. 9, e1002980, doi: 10.1371/journal.pcbi.1002980 (2013
50. Kumar, V. S., & Maranas, C. D. GrowMatch: an automated method for reconciling in silico/in vivo growth predictions. PLoS Comput. Biol. 5, e1000308, doi: 10.1371/journal.pcbi.1000308 (2009
51. Ebrahim, A., Lerman, J. A., Palsson, B. O., & Hyduke, D. R. COBRApy: COnstraints-Based Reconstruction and Analysis for Python. BMC Syst. Biol. 7, 74, doi: 10.1186/1752-0509-7-74 (2013
52. Oliphant, T. E. Python for scientific computing. Comput. Sci. Eng. 9, 10-20 (2007
53. Nemoto, S., Fergusson, M. M., & Finkel, T. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1 alpha. J. Biol. Chem. 280, 16456-16460, doi: 10.1074/jbc.M501485200 (2005